FATE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Fate Therapeutics (FATE) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FATE is expected to report earnings to rise 9.42% to -43 cents per share on March 03

Fate Therapeutics FATE Stock Earnings Reports

Q4'24

Est.

$-0.44

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.13

Q1'24

Beat

by $0.01

Q4'23

Beat

by $0.07

The last earnings report on November 12 showed earnings per share of -40 cents, beating the estimate of -41 cents. With 456.18K shares outstanding, the current market capitalization sits at 214.12M.

View a ticker or compare two or three

Compare

FATE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For FATE
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12278 Scripps Summit Drive

Phone

+1 858 875-1800

Employees

220

Web

https://www.fatetherapeutics.com